Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series

PURPOSE: Many studies report the triple negative breast cancer (TNBC) as the worst subgroup, as such patients do not benefit from anti-hormonal therapy and human epidermal growth factor receptor 2 (HER2) antagonists. While HER2 overexpression was a poor prognostic factor in breast cancer before tras...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosar, Rusen, Sut, Necdet, Ozen, Alaattin, Tastekin, Ebru, Topaloglu, Sernaz, Cicin, Irfan, Nurlu, Dilek, Ozler, Talar, Demir, Seda, Yıldız, Gokay, Şenödeyici, Eylül, Uzal, Mustafa Cem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467695/
https://www.ncbi.nlm.nih.gov/pubmed/36105268
http://dx.doi.org/10.2147/BCTT.S380754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467695/
https://www.ncbi.nlm.nih.gov/pubmed/36105268
http://dx.doi.org/10.2147/BCTT.S380754

Ejemplares similares